Replies to post #373055 on Elite Pharmaceuticals Inc (ELTP)

[IB_]

The only shareholder that I see benefitting from this low share price, is the CEO,NasRat !!!!!!!!!!!!!!!
He accumulates more shares when the price is low, soaking up those extra 100's of Millions of shares he added to the authorized ................

How long will it be till NasRat "Controls" 90% of Elite's shares ???????

IB_

[no2koolaid]

When conducting an analysis, it is important to look not only at the known but, upon analysis, the more obviousness of the unknown; which is often the basis for thoughtful analysis and assessment. With that as my grounding...

As to Elite, assessing business success is done when recognizing the CEO, with a company near bankruptcy (likely Chp 7 liquidation), faced with an FDA CRL and the inability to fund the business, is able to turn that around by pivoting to a new product line, attaining 4X revenues over the last three years and, in what is the sine quo non of business success - profitability, then gets a business loan that serves as proof of business concept and makes a strategic asset purchase (the building) that prevents a notable capital outlay, in 12 years. Further, if we consider when the company became profitable, it is sooner than Moderna, Alnylam, and a number of other larger firms. With these irrefutable facts, my evidence lies in the dulcet claims of Sherlock Holmes...

When you have eliminated all which is impossible, then whatever remains, however improbable, must be the truth.

As there is NO evidence manipulation is NOT occurring, my argument supports the inference that it is. PERIOD!